The objective of this scoping review is to obtain an estimate of the size and nature of the scientific literature available on digital technologies with the potential to benefit or disrupt key public health functions, focusing on infectious disease surveillance, prevention and control.
In 2019, the European Centre for Disease Prevention and Control (ECDC) initiated a project to assess the possible impact of technical advances on its key functions. The results of the project will serve as a source of information for ECDC and its main stakeholders in deciding how to prepare for, and possibly benefit from, technological advances to further improve communicable disease surveillance, prevention and control.
This document aims to help public health authorities in EU/EEA countries and the UK in their tracing and
management of persons, including healthcare workers, who have had contact with COVID-19 cases.
This report seeks to review the progress made in the ECDC response plan to control and manage the threat of drug-resistant gonorrhoea in Europe over the preceding two years, using the data collected for 2019.
The toolkit contains template materials and some suggested key messages focusing on self-medication with antibiotics, ideas for awareness raising activities, and suggested tactics for getting the messages across to the general public regarding prudent use of antibiotics, especially to people self-medicating with antibiotics.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
This study provides insights for national public health authorities into the factors behind the spread of vaccine misinformation online and the options and capacities needed for responding to it.
This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.
Urgent action is required to improve efforts to prevent hepatitis B and C infections in the EU/EEA and the UK if the region is to meet the 2020 targets for the elimination of viral hepatitis as a serious threat to public health. Significant gaps in the reported data in relation to prevalence and prevention of HBV and HCV in EU/EEA and the UK present a major challenge to monitoring progress towards the targets for elimination of hepatitis.